Canada flouting USMCA with dairy import quota rules, says U.S. industry
Last week, Mr. Trump sent a letter to Prime Minister Mark Carney threatening to impose more tariffs on a number of Canadian goods and complaining about Canada's protectionist measures on supply-managed products such as dairy. The deadline for the Canada-U.S. trade deal has been postponed from July 21 to Aug. 1.
U.S. exporters want Canadian retailers and food-service companies to be able to import dairy tariff-free under the U.S.-Mexico-Canada Agreement. But Canada's rules allow only processors and distributors to import U.S. dairy products without facing levies that can surpass 250 per cent. A limited amount can be imported without duties under a tariff rate quota, or TRQ.
The U.S. has long argued Canada's TRQ licence rules are a breach of USMCA, and are why exporters have been unable to sell into the Canadian market at the volumes negotiated in 2018.
'It is just ridiculous that you would give the vast majority of the tariff rate quota licences to our competitors in the Canadian dairy industry who – frankly – have their own motivations for what they want to bring in,' said Shawna Morris, executive vice-president of trade policy and global affairs at the U.S. Dairy Export Council.
Canadian grocers and distributors also say the system benefits the dairy industry, and reduces the variety of products available to consumers from U.S. producers.
The dairy industry's outsized political influence, explained in charts
Bill protecting supply management from trade negotiations to become law
Canada has so far held firm against the U.S.'s demands. However, the stakes are higher today now that Washington and the U.S. dairy industry has Canada's supply-management system in its sights. If U.S. exporters prevail with securing changes to the quota system, shoppers here could see a wider range of products on their grocer's shelves at the expense of the Canadian dairy industry.
The U.S. Dairy Export Council has been assured by the Trump administration that overhauling the rules is a priority, Ms. Morris said. However, the government of Canada is not planning to change the administration and allocation policies under USMCA, Jason Kung, spokesperson for Global Affairs Canada, said in a statement.
'This government remains committed to maintaining, protecting and defending supply management, and standing up for the industries, farmers, workers and the communities they support.'
The USMCA trade agreement gave the U.S. dairy industry expanded access to approximately 3.5 per cent of the Canadian domestic market.
The value of exports has grown to US$1.18-billion in 2024 from US$697.09-million in 2016, according to the United States Department of Agriculture.
But the U.S. has not penetrated the market to the degree it negotiated, Ms. Morris said.
Market forces are a factor. The fill rate – the percentage of the tariff-free quota actually used to import products – is high for foods like butter and cheese, where there is strong consumer demand.
However, the rate falls far below its limits for a number of products, Ms. Morris said. She blames Canada's rules around imports.
These processors directly compete with the U.S. dairy exporters, so have less incentive to import, Ms. Morris said.
The licensing rules also skew the type of product imported into Canada, said Santo Ligotti, spokesperson for the Retail Council of Canada (RCC).
The RCC has long advocated for retailers to be allocated tariff-rate quotas under USMCA, he said. But the government is not prioritizing retailers or Canadian consumers, he said.
'When it comes to dairy, the Canadian government always looks to favour producer interests over consumer interests,' Mr. Ligotti said.
Consider cheese. In 2024, 83 per cent of the TRQ allotment for 'cheese of all types' was filled – the highest rate across all categories.
Because the licences are granted at a higher rate to processors, the vast majority falls into three categories: mozzarella, cheddar and grated and powdered cheese.
These processors can also import cheese under a second category: industrial. This includes bulk cheeses used for food manufacturing. Processors import less of the available quota under this category.
This is unfair and goes against the spirit of the trade agreement and free market economics, said Joe Dal Ferro, president Finica Food Specialties, a distributor that sells cheese to all major retailers across Canada.
The processor is not interested in providing variety to the Canadian consumer, said Mr. Dal Ferro, who is also chair of the International Cheese Council of Canada. They will only import cheese that does not compete with what they offer, he said.
The U.S. launched complaints against Canada in 2021 and 2023, but the panel found in the last dispute that Canada was not in breach of its commitments under USMCA. The panel decided that the trade deal gave Canada the right to exercise broad discretion in how it allocates quota, said Matthew Kronby, a partner in the international trade and investment practice at Osler, Hoskin & Harcourt LLP. Mr. Kronby has represented the Canadian dairy industry in its trade disputes with the U.S.
Total market access lost to foreign competitors for dairy products under all Canada's trade commitments, including USMCA, was estimated at approximately 10 per cent of domestic production once the agreements will be fully implemented, Agriculture and Agri-Food Canada said in a statement.
Dairy Farmers of Canada estimates the loss to be closer to 18 per cent of domestic production.
'When previous governments conceded access to our domestic market, we yielded part of our milk production to other countries in perpetuity,' said David Wiens, president of Dairy Farmers of Canada. 'That's market share our farmers will never recover.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Montreal Gazette
18 minutes ago
- Montreal Gazette
Opinion: Provinces must align on health care, not just trade
Op Eds We can borrow a line from Charles Dickens to describe our current state of politics in this country: 'It was the best of times, it was the worst of times.' The 'worst of times' describes the international trade turmoil caused by Donald Trump's fluctuating tariffs and erratic deal-making, with significant implications for our economy. What is less frequently discussed is 'the best of times' impact — the unity the U.S. president's actions has created among premiers and the federal government. Pan-Canadian trade barriers are falling, and interprovincial project ideas abound. This is good news for Canada, even as a possible trade deal with the United States presumably wends closer. As patient-partners in health research, and part of a non-profit organization that helps cancer patients receive essential treatments, we ask: If we can find equal footing among the provinces and territories on trade, why not on health care? Why can't we streamline access to medically necessary treatment for patients across the country who are badly in need of them? For many, this is a matter of life or death. At the moment, provincial and territorial governments make their own decisions about what drugs to reimburse for eligible people and under what conditions. There are many instances across the country where governments don't reimburse people for essential medications at all, leaving patients to find the money on their own. This includes cancer treatments. Sometimes this means people must go without necessary drugs or necessary food. This is the 'choice' our so-often-called 'patchwork quilt' of coverage sometimes provides. The federal government also has its own drug plans for groups under its jurisdiction — and recently, for contraceptives and diabetes medication through the 2024 Pharmacare Act (in provinces that have finalized their agreements with the federal government). Now that we have decided to become Team Canada on trade, there is no reason not to extend this to drug access. During his election campaign, Prime Minister Mark Carney talked about 'Canada Strong,' his plan to unite, secure, protect and build Canada, including comprehensive measures to build and protect our health care system. He talked about adding doctors, building hospitals and delivering better mental health services. He said we would build a stronger health care system. A stronger health care system includes ensuring that people in Canada have equal access to medically necessary services, and that the coverage is portable across the country. These are among the five key principles underpinning the Canada Health Act. Provinces are already on board for getting people medically necessary treatments. Last month, Ontario Premier Doug Ford, who heads the Council of the Federation, comprising all provincial and territorial premiers, said one of their aims is to accelerate getting life saving medications to people who need them. So if every level of government supports the need for medically necessary services — and drug treatments should surely fit into that category — why are we not tearing down the barriers to our patchwork quilt of public drug reimbursement plans? Where you live in the country should not determine whether or not you receive essential medications. Access to health care in Canada — including life-saving medications — should be seamless across provincial and territorial borders. It is not only the right thing to do for patients, but it is also a boon to the economy — getting people healthy and contributing to our society in any way they can. So we ask Carney and the Council of the Federation: If we can find practical solutions to remove trade barriers that are bad for our economy, why can't we find a practical solution to the barrier of unequal access to medically necessary treatments across this country, too?


Globe and Mail
18 minutes ago
- Globe and Mail
Brazil requests consultations at World Trade Organization over Trump's tariffs
RIO DE JANEIRO (AP) — Brazil requested consultations at the World Trade Organization over tariffs imposed by U.S. President Donald Trump against the South American nation that went into effect on Wednesday. Trump has directly tied the 50% tariff on many imported Brazilian goods to the judicial situation of his embattled ally, former President Jair Bolsonaro, who is currently under house arrest. "The United States has flagrantly violated key commitments the country has agreed upon at the WTO, such as the principle of the most favored nation and tariff ceilings negotiated at that organization,' Brazil's foreign ministry said in a statement. The most favored nation principle is a cornerstone of Geneva-based WTO, whose aim is to get countries to respect trade agreements. The principle directs its members to treat each other equally in trade. WTO panels are set if no agreement is reached in disputes between members. 'Brazil's government reiterates its availability for negotiation and hopes these consultations contribute to a solution to the matter,' the Brazilian foreign office said. The U.S. government has not made comments about Brazil's move. Earlier, a Brazilian government official told The Associated Press Brazil understands that the case could drag on and there's no guarantee of success. The official, who wasn't authorized to discuss the matter publicly, spoke on condition of anonymity. Brazilian President Luiz Inácio Lula da Silva has repeatedly said that the trade body needs a revamp to be enabled to mediate in conflicts. Brazil's government estimates that 35.9% of the country's goods shipped to the American market have been affected. That is about 4% of Brazil's total exports. Trump directly tied the 50% tariff on imported Brazilian goods to the judicial situation of his embattled ally, former President Jair Bolsonaro, who is currently under house arrest. Last month, Bolsonaro was ordered to wear an electronic ankle monitor and to obey a curfew while the proceedings are underway. Lula is yet to speak about the move. On Tuesday, the leftist leader said he wouldn't call Trump to talk about trade 'because he doesn't want to' speak about it. Lula said that he might instead 'invite him to attend (November's climate summit) COP in Belem.'


Globe and Mail
18 minutes ago
- Globe and Mail
Strategic Growth in the Global X-Ray Detectors Market (2025-2030)
"Originally a part of Varian Imaging, Varex Imaging Corporation has expanded to become a world leader in producing and selling medical imaging devices, catering to industries like cargo screening and border security." key players operating in the global X-ray detectors market are Varex Imaging (US), Canon (Japan), Thales Group (France), Analogic Corporation (US), Agfa-Gevaert Group (Belgium), Carestream Health (US) The global X-ray detectors market is on a trajectory of sustained growth, projected to expand from US$3.4 billion in 2025 to US$4.4 billion by 2030, advancing at a CAGR of 5.5%. As digital transformation accelerates across healthcare, defense, and industrial sectors, X-ray detector technologies have become a key enabler of high-stakes decision-making, operational efficiency, and national security. For C-level executives and senior decision-makers, this evolution represents more than a technological upgrade—it's a strategic opportunity for ROI, innovation, and competitive advantage. Download PDF Brochure: Healthcare, Defense, and Beyond: Why the X-Ray Detectors Market Is Booming X-ray detectors are no longer limited to diagnostic imaging in hospitals. They are transforming border security, aerospace inspections, homeland defense, and precision medicine, thanks to major advances in flat-panel technologies, backscatter X-rays, and photon-counting detectors. Here's why this market matters for enterprise leaders: Security and Defense Digitization: Airports, seaports, and critical checkpoints are integrating advanced X-ray imaging to combat emerging threats. High-resolution, real-time detection of concealed weapons, explosives, and contraband is now critical for national and global security. Medical Imaging Modernization: As healthcare systems digitize globally, the shift from analog to flat-panel digital radiography ensures higher throughput, faster diagnostics, and improved patient safety—delivering both clinical value and operational cost savings. Industrial Inspection & Automation: Rugged and handheld detectors are increasingly used for non-destructive testing (NDT) in aerospace, oil & gas, and manufacturing—ensuring safety, compliance, and uptime in mission-critical systems. Market Leaders & Strategic Differentiators Varex Imaging (US): Diversification and Deep Sector Expertise Varex Imaging exemplifies the market's transition from traditional radiology to multisector innovation. With strong capabilities across medical, industrial, and security imaging, Varex's inorganic growth strategy—driven by acquisitions and global expansion—makes it a versatile partner for OEMs and system integrators. Their investment in AI-enabled imaging and advanced detector materials positions them as a formidable player in custom and scalable detector design. Thales Group (France): Security and Medical Fusion Through its Trixell division, Thales provides state-of-the-art flat-panel detectors for OEMs across radiography, fluoroscopy, and cardiovascular applications. The company's legacy in defense and secure communications complements its healthcare imaging operations—making it uniquely positioned to lead in dual-use imaging systems for civilian and military applications. Canon Inc. (Japan): Ecosystem Strength in Healthcare Canon leverages its expansive global network and R&D capabilities across digital radiography, CT, and MRI systems. The firm's seamless integration of X-ray detectors within a broader portfolio of diagnostic tools enables healthcare institutions to modernize imaging infrastructure holistically—reducing downtime, radiation exposure, and diagnostic uncertainty. Request Sample Pages : Technology Spotlight: Flat-Panel Detectors Drive Value Flat-panel detectors (FPDs), particularly those using cesium iodide (CsI), dominate the technology landscape due to: Superior Image Resolution: Ideal for early detection of chronic conditions like cancer or cardiovascular disease. Reduced Radiation Dosage: Enhances patient safety and supports regulatory compliance. Faster Image Acquisition: Improves clinical workflow and diagnostic throughput. With hospitals and imaging centers under pressure to improve diagnostic accuracy while managing costs, FPDs represent a high-ROI investment with proven clinical and operational benefits. Geographic Growth Hotspots: Strategic Markets to Watch North America remains the most mature market, driven by advanced infrastructure, strong reimbursement systems, and early adoption of AI-enhanced imaging. Asia Pacific is rapidly expanding due to increased healthcare spending, government initiatives in rural diagnostics, and a rising middle class demanding high-quality imaging. Europe continues to innovate through public-private partnerships, particularly in preventive care and cancer diagnostics. Global players are expected to deepen regional partnerships and invest in localized production to navigate shifting trade regulations and accelerate time to market. Investment Outlook: ROI and Strategic Benefits For C-suite leaders, the X-ray detectors market offers: Long-term ROI: Upgrading to advanced detectors can result in 10–20% operational efficiency gains, reduced maintenance costs, and improved service turnaround times. Innovation Advantage: Early investment in photon-counting or AI-integrated detectors can differentiate offerings in competitive bids or tenders. Sustainability Impact: Digital detectors reduce chemical waste (vs. film-based systems), support greener operations, and align with ESG mandates. Future Outlook: AI, Photon Counting, and Space Applications Looking forward, the X-ray detector market is being reshaped by: Photon-Counting Detectors: Emerging as a disruptive force with unparalleled resolution and low-dose imaging for precision diagnostics. AI & Predictive Imaging: Integration with artificial intelligence enhances image interpretation, triage, and workflow automation—enabling faster, more accurate decisions. Space & Deep Tech Applications: X-ray systems are being explored for use in satellite inspections, asteroid mining, and extraterrestrial exploration, unlocking new industrial frontiers. Key Takeaways for Decision-Makers Strategic Priority Value Proposition Modernize Imaging Infrastructure Enhance speed, accuracy, and ROI Align with National Security Demands Adopt advanced X-ray tech for defense & border safety Leverage ESG & Sustainability Transition to greener, digital imaging systems Capitalize on Global Expansion Target high-growth regions and partner with OEMs Invest in R&D and Innovation Future-proof your portfolio through emerging tech Ready to Lead the Next Wave of Imaging Innovation? The X-ray detectors market presents an intersection of innovation, resilience, and growth. Enterprises that invest now in next-generation detector technologies will be better equipped to meet rising demand, navigate regulatory shifts, and deliver exceptional value to customers. For more information, Inquire Now!